Latest Biotech News

Harvard bioengineers designed ultrathin, flexible mesh microelectrode arrays that integrate seamlessly into the developing neural plate of tadpole embryos. This innovative implant expands...

Researchers at Monash University and oNKo-Innate identified a gene whose inhibition in natural killer (NK) cells amplifies their sensitivity to IL-15, an immune growth factor imperative for cancer...

Agilent Technologies introduced the InfinityLab Pro iQ Series, a new generation of liquid chromatography-mass spectrometry platforms designed for pharmaceutical, biopharmaceutical, and...

A study revealed that cancer cells utilize sulfated glycosaminoglycans on their surface to mediate uptake of lipoproteins carrying α-tocopherol, a form of vitamin E that inhibits ferroptosis, an...

BioNTech agreed to acquire CureVac for $1.25 billion in an all-stock transaction resolving pending patent litigation and enhancing BioNTech’s manufacturing and oncology pipeline. The deal...

Nuvation Bio’s FDA approval of Ibtrozi, a next-generation tyrosine kinase inhibitor for ROS1-positive non-small cell lung cancer, demonstrates clinical efficacy with favorable safety, offering a...

Genentech announced layoffs impacting 143 employees at its South San Francisco headquarters amid operational realignment and cost optimization efforts. The workforce reduction follows previous...

BioNTech is acquiring CureVac in a $1.25 billion all-stock deal, resolving ongoing mRNA patent litigation and gaining CureVac’s advanced manufacturing capabilities. This strategic purchase...

The FDA approved Nuvation Bio’s Ibtrozi for treating ROS1-positive non-small cell lung cancer, marking the company's entry into a competitive market dominated by Pfizer, Bristol Myers Squibb, and...

Merck received FDA approval for Enflonsia (cesrovimab), a long-acting monoclonal antibody preventing RSV lower respiratory tract disease in infants, joining existing pediatric RSV antibody...

GSK presented updated clinical trial data for Blenrep combined with Pomalyst and dexamethasone demonstrating prolonged progression-free survival in relapsed or refractory multiple myeloma...

Researchers successfully demonstrated a brain-to-voice neuroprosthesis that synthesizes speech instantaneously from neural signals in a man with ALS, capturing prosodic features such as tone and...

Deep Apple Therapeutics and Novo Nordisk entered a collaboration valued up to $812 million to develop small molecule therapies targeting non-incretin GPCRs for cardiometabolic diseases, including...

Basecamp Research unveiled BaseData, a 9.8-billion protein sequence database encompassing one million novel species, addressing critical data shortages hindering AI-driven biological discovery....

Enduro Genetics presented synthetic biology innovations enabling enhanced monoclonal antibody production by engineering cellular pathways to counteract micro-evolution-induced productivity loss in...

A team engineered a green-light-activatable form of penicillin, enabling spatial and temporal control of antibiotic activity to precisely target infections while reducing systemic exposure and...

Regeneron Genetics Center has launched a large-scale proteomics research initiative involving nearly 200,000 patient samples from Geisinger, using Thermo Fisher's Olink Explore HT platform. This...

A novel brain-computer interface featuring 256 implanted electrodes successfully enabled a man with severe speech paralysis from ALS to communicate expressively and modulate his voice in real...

Capricor Therapeutics has been issued a Form 483 following an FDA inspection of its manufacturing facility, citing several observations primarily related to quality systems and documentation....

Regeneron Genetics Center (RGC) has initiated an extensive proteomics research project analyzing nearly 200,000 Geisinger Health System patient samples using Thermo Fisher Scientific’s Olink...